Sage Journals: Discover world-class research

Retricted access

Research article

First published 2008-7

Association Between Hospitalization and Discontinuity of Medication Therapy Used in the Community Setting in the Netherlands

Rutger Stuffken, Eibert R Heerdink, Fred HP de Koning [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2020-10

Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies

Marisa P McGinley, Philip A Cola, Robert J Fox [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-2

DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial

John R Corboy, Robert J Fox, Gary Cutter [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-9

Systematic review of the clinical impact of dual antiplatelet therapy discontinuation after acute coronary syndromes

Uwe Zeymer, Anja Becher, Em Jennings [...]

European Heart Journal: Acute Cardiovascular Care

Retricted access

Research article

First published 2019-4

Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60

Le H Hua, Tracey H Fan, Devon Conway [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-3

Early Symptom Improvement and Discontinuation of 5-α-Reductase Inhibitor (5ARI) Therapy in Patients With Benign Prostatic Hyperplasia (BPH)

Eric J. Kruep, Emily Phillips, Susan Hogue [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2014-7

Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy

Richard E. Nelson, Robert Hoop, Eli Korner [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025-8

Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease

You-Ri Kang, Hyunjin Ju, Ki Hoon Kim [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-3

Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri ® Observational Program (TOP)

Helmut Butzkueven, Maria Trojano, Ludwig Kappos [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2001-05

Why Do Older Women Discontinue Hormone Replacement Therapy?

Meredith M. Regan, Sarah K. Emond, Mary J. Attardo [...]

Journal of Women's Health

Search results